Preclinical imaging and radiotherapy of prostate cancer using the theranostic twins(68Ga/177Lu)-radiolabeled peptides

被引：0
|
作者：
Lim, J. C. [1 ]
Cho, E. H. [1 ]
Lee, S. Y. [1 ]
Dho, S. H. [1 ]
Kim, S. Y. [1 ]
Jung, S. H. [1 ]
机构：
[1] Korea Atom Energy Res Inst, Daejeon, South Korea
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 118卷
关键词：
Theranosis; Prostate cancer; Bombesin; Radionuclide;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [21] Preclinical Evaluation of 68Ga/177Lu labeled novel FAP-targeted peptide for tumor radionuclide imaging and therapy
    Wang, Weichen
    Wang, Rang
    Huang, MingXing
    Tian, Rong
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [22] Unusual Case of Diffuse Penile Metastasis of Prostate Cancer on 68Ga PSMA PET/CT Imaging and 177Lu PSMA Posttherapy Scintigraphy
    Vadi, Shelvin Kumar
    Kumar, Rajender
    Mittal, Bhagwant Rai
    Parihar, Ashwin Singh
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 276 - 278
  • [23] Preclinical evaluation of Y-90 and Lu-177 radiolabeled peptides for in vivo targeted radiotherapy of prostate cancer
    Hoffman, TJ
    Smith, CJ
    Gali, H
    Owen, NK
    Sieckman, GL
    Foster, BN
    Mazuru, DG
    Shelton, TD
    Volkert, WA
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 462 - 463
  • [24] [68Ga]/[177Lu]P17-087: A potential theranostic agent targeting PSMA expressing tumor
    Kung, Hank
    Choi, Seok Rye
    Zha, Zzhihao
    Ploessl, Karl
    Alexoff, David
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S99 - S100
  • [25] Development of radiopharmaceuticals to target neurotensin receptors based on 68Ga and 177Lu
    Niculae, Dana
    Mihon, Mirela
    Leonte, Radu
    Silisteanu, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [26] Potential airborne releases of 68Ga and 177Lu: a method of preventive assessment
    Marengo, M.
    Rubow, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S734 - S734
  • [27] Development of [68Ga]Ga/[177Lu]Lu-FAPI using dual-chelator DOTA-HBED
    Luo, Yang
    Hong, Haiyan
    Jin, WenBin
    Yan, Li
    Huang, Yanran
    Wang, Ran
    Qiao, Jinping
    Zhu, Lin
    Kung, Hank F.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [28] Development of 68Ga/177Lu-LNC1011 for theranostics of prostate cancer
    Yang, Hongzhang
    Wen, Xuejun
    Guo, Huifeng
    Zhang, Jingjing
    Zhou, Zijian
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [29] [68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4
    Lau, Joseph
    Kwon, Daniel
    Rousseau, Etienne
    Zhang, Zhengxing
    Zeisler, Jutta
    Uribe, Carlos F.
    Kuo, Hsiou-Ting
    Zhang, Chengcheng
    Lin, Kuo-Shyan
    Benard, Francois
    MOLECULAR PHARMACEUTICS, 2019, 16 (11) : 4688 - 4695
  • [30] Theranostic perspectives of [67Ga/111In/177Lu]NeoBOMB1 in prostate cancer - First evidence for clinical translation with [68Ga]NeoBOMB1 and PET/CT
    Nock, B. A.
    Maina-Nock, T.
    Kaloudi, A.
    Giarika, A.
    Lymperis, E.
    Singh, A.
    Kulkarni, H. R.
    Klette, I.
    Krenning, E. P.
    de Jong, M.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S49 - S49
12345